Epidermolysis Bullosa Dystrophic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-06-22
Clinical Trial Update: Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB) [Phase 3]
Phase 3 trial evaluating Apligraf for nonhealing wounds in patients with epidermolysis bullosa (junctional or dystrophic) was terminated, wi…